BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 21992731)

  • 1. Lung cancer in never smokers.
    Torok S; Hegedus B; Laszlo V; Hoda MA; Ghanim B; Berger W; Klepetko W; Dome B; Ostoros G
    Future Oncol; 2011 Oct; 7(10):1195-211. PubMed ID: 21992731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung cancer in never smokers: a review.
    Subramanian J; Govindan R
    J Clin Oncol; 2007 Feb; 25(5):561-70. PubMed ID: 17290066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic basis for susceptibility to lung cancer: Recent progress and future directions.
    Yokota J; Shiraishi K; Kohno T
    Adv Cancer Res; 2010; 109():51-72. PubMed ID: 21070914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung cancer in never smokers: change of a mindset in the molecular era.
    Lee YJ; Kim JH; Kim SK; Ha SJ; Mok TS; Mitsudomi T; Cho BC
    Lung Cancer; 2011 Apr; 72(1):9-15. PubMed ID: 21272954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lung cancer in smokers and never-smokers].
    Helland A; Brustugun OT
    Tidsskr Nor Laegeforen; 2009 Sep; 129(18):1859-62. PubMed ID: 19844277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung cancer in never smokers--a review.
    Couraud S; Zalcman G; Milleron B; Morin F; Souquet PJ
    Eur J Cancer; 2012 Jun; 48(9):1299-311. PubMed ID: 22464348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 mutations and exposure to environmental tobacco smoke in a multicenter study on lung cancer.
    Husgafvel-Pursiainen K; Boffetta P; Kannio A; Nyberg F; Pershagen G; Mukeria A; Constantinescu V; Fortes C; Benhamou S
    Cancer Res; 2000 Jun; 60(11):2906-11. PubMed ID: 10850436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GSTM1 and CYP1A1 polymorphisms, tobacco, air pollution, and lung cancer: a study in rural Thailand.
    Pisani P; Srivatanakul P; Randerson-Moor J; Vipasrinimit S; Lalitwongsa S; Unpunyo P; Bashir S; Bishop DT
    Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):667-74. PubMed ID: 16614107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung cancer in never smokers: disease characteristics and risk factors.
    Pallis AG; Syrigos KN
    Crit Rev Oncol Hematol; 2013 Dec; 88(3):494-503. PubMed ID: 23921082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutathione S-transferase mu1 and N-acetyltransferase 2 genetic polymorphisms and exposure to tobacco smoke in nonsmoking and smoking lung cancer patients and population controls.
    Nyberg F; Hou SM; Hemminki K; Lambert B; Pershagen G
    Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):875-83. PubMed ID: 9796632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of environmental tobacco smoke on the incidence of mutations in epidermal growth factor receptor gene in never-smoker patients with non-small-cell lung cancer.
    Lee YJ; Cho BC; Jee SH; Moon JW; Kim SK; Chang J; Chung KY; Park IK; Choi SH; Kim JH
    J Clin Oncol; 2010 Jan; 28(3):487-92. PubMed ID: 20008630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular genetics of lung cancer in people who have never smoked.
    Subramanian J; Govindan R
    Lancet Oncol; 2008 Jul; 9(7):676-82. PubMed ID: 18598932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BioCAST/IFCT-1002: epidemiological and molecular features of lung cancer in never-smokers.
    Couraud S; Souquet PJ; Paris C; Dô P; Doubre H; Pichon E; Dixmier A; Monnet I; Etienne-Mastroianni B; Vincent M; Trédaniel J; Perrichon M; Foucher P; Coudert B; Moro-Sibilot D; Dansin E; Labonne S; Missy P; Morin F; Blanché H; Zalcman G;
    Eur Respir J; 2015 May; 45(5):1403-14. PubMed ID: 25657019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATM polymorphisms and risk of lung cancer among never smokers.
    Lo YL; Hsiao CF; Jou YS; Chang GC; Tsai YH; Su WC; Chen YM; Huang MS; Chen HL; Yang PC; Chen CJ; Hsiung CA
    Lung Cancer; 2010 Aug; 69(2):148-54. PubMed ID: 20004998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
    Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long exposure of environmental tobacco smoke associated with activating EGFR mutations in never-smokers with non-small cell lung cancer.
    Kawaguchi T; Ando M; Kubo A; Takada M; Atagi S; Okishio K; Asami K; Matsumura A; Tsujino K; Ignatius OS; Sasaki H
    Clin Cancer Res; 2011 Jan; 17(1):39-45. PubMed ID: 21059816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 and K-ras mutations in lung cancers from former and never-smoking women.
    Vähäkangas KH; Bennett WP; Castrén K; Welsh JA; Khan MA; Blömeke B; Alavanja MC; Harris CC
    Cancer Res; 2001 Jun; 61(11):4350-6. PubMed ID: 11389059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung cancer risk in nonsmokers and GSTM1 and GSTT1 genetic polymorphism.
    Malats N; Camus-Radon AM; Nyberg F; Ahrens W; Constantinescu V; Mukeria A; Benhamou S; Batura-Gabryel H; Bruske-Hohlfeld I; Simonato L; Menezes A; Lea S; Lang M; Boffetta P
    Cancer Epidemiol Biomarkers Prev; 2000 Aug; 9(8):827-33. PubMed ID: 10952100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients.
    Bae NC; Chae MH; Lee MH; Kim KM; Lee EB; Kim CH; Park TI; Han SB; Jheon S; Jung TH; Park JY
    Cancer Genet Cytogenet; 2007 Mar; 173(2):107-13. PubMed ID: 17321325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers.
    Le Calvez F; Mukeria A; Hunt JD; Kelm O; Hung RJ; Tanière P; Brennan P; Boffetta P; Zaridze DG; Hainaut P
    Cancer Res; 2005 Jun; 65(12):5076-83. PubMed ID: 15958551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.